JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2006;59:935-941; doi:10.1136/jcp.2005.034629
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nowicki, M
Right arrow Articles by Miskowiak, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nowicki, M
Right arrow Articles by Miskowiak, B
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Bone Marrow Diseases
*Leukemia, Childhood

ORIGINAL ARTICLE

The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow

M Nowicki1,2, D Ostalska-Nowicka3, A Konwerska2, B Miskowiak2,4

1 Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland
2 Department of Histology and Embryology, Poznan University of Medical Sciences
3 Department of Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences
4 Department of Optometry and Biology of the Visual System, Poznan University of Medical Sciences

Correspondence to:
M Nowicki
Department of Histology and Embryology, Poznan University of Medical Sciences, ul. Swiecickiego 6, 60-781 Poznan, Poland;mnowicki{at}amp.edu.pl Aims: To estimate the expression of substance P in the haematopoietic cells of hypoplastic bone marrow and define its relationship with the course of bone marrow hypoplasia.

Methods: Bone marrow specimens were obtained from 42 children with bone marrow hypoplasia who were hospitalised in the Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland, between 1996 and 2003. Substance P and Ki-67 expression were evaluated using immunochemical and hybridocytochemical assays.

Results: The expression of substance P (as evidenced by both immunocytochemical and hybridisation techniques) was confirmed in the cytoplasm of B lymphocytes in 8 of 11 children who developed acute leukaemia in 45 (SD 12) days. The percentage of substance P-positive cells ranged from 67.6 to 95.8 (mean of 81.5% cells with immunocytochemistry and 84.3% with in situ hybridisation). The risk of development of leukaemia secondary to bone marrow hypoplasia was found to be significant (p<0.001) in those children who expressed substance P in normal-looking lymphocytes at the initial bone marrow evaluation.

Conclusions: The presence of substance P in B lymphocytes of hypoplastic bone marrow may predict its neoplastic transformation. A marked correlation between substance P-positive bone marrow pattern and the expansion of tumour cells may prove the potential value of this oligopeptide in the pathogenesis of leukaemia.


Abbreviations: ALL, acute lymphoblastic leukaemia; ANLL, acute non-lymphoblastic leukaemia; ICC, immunocytochemistry; IL1, interleukin 1; ISH, in situ hybridisation; NK-1R, nerokinin-1 receptor




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M. Nowicki, D. Ostalska-Nowicka, B. Kondraciuk, and B. Miskowiak
The significance of substance P in physiological and malignant haematopoiesis
J. Clin. Pathol., July 1, 2007; 60(7): 749 - 755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.